MedTrace Logo

Treatment of Aspergillus Fumigatus (a Fungal Infection) in Patients With Cystic Fibrosis

NCT00528190 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 35

Last updated 2017-05-10

Study results available
· View outcomes & findings →

Summary

This clinical trial will attempt to determine whether we can improve clinical outcomes for patients with cystic fibrosis who are infected with a fungus called Aspergillus fumigatus.

Conditions

Interventions

DRUG

Itraconazole

Oral Itraconazole 5mg/kg/day or identical placebo for 24 weeks

Sponsors & Collaborators

  • The Hospital for Sick Children

    collaborator OTHER

  • Canadian Cystic Fibrosis Foundation

    collaborator OTHER

  • The Physicians' Services Incorporated Foundation

    collaborator OTHER

  • Ottawa Hospital Research Institute

    lead OTHER

Principal Investigators

  • Shawn Aaron, MD · OHRI

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
6 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-10-31
Primary Completion
2010-08-31
Completion
2011-05-31

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00528190 on ClinicalTrials.gov